Lucas K Vitzthum1, Helen Park1, Kaveh Zakeri2, Elena S Heide1, Vinit Nalawade1, Arno J Mundt1, Florin Vaida3, James D Murphy4, Loren K Mell5. 1. Department of Radiation Medicine and Applied Sciences, University of California San Diego, San Diego, California. 2. Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York. 3. Department of Biostatistics, University of California San Diego, San Diego, California. 4. Department of Radiation Medicine and Applied Sciences, University of California San Diego, San Diego, California; Clinical and Translational Research Institute, University of California San Diego, San Diego, California. 5. Department of Radiation Medicine and Applied Sciences, University of California San Diego, San Diego, California; Clinical and Translational Research Institute, University of California San Diego, San Diego, California. Electronic address: lmell@ucsd.edu.
Abstract
PURPOSE: Older patients undergoing radiation therapy (RT) for pelvic malignancies are at increased risk for pelvic fracture, which is associated with significant morbidity and mortality. RT techniques such as brachytherapy or intensity modulated RT (IMRT) allow for more conformal dose distributions, but it is not known whether the risk for pelvic fracture varies by RT modality. METHODS AND MATERIALS: This observational cohort study involved 28,354 patients ≥65 years old, treated with RT for pelvic malignancies. We evaluated the relative risk of pelvic fracture by type of RT when accounting for baseline factors. To test for nonspecific effects, we also evaluated risk of nonpelvic fractures in the same population. RESULTS: The 5-year incidence of pelvic fractures was 12.7% (95% confidence interval [CI], 11.6%-13.8%), 11.8% (10.8%-12.8%), and 3.7% (3.4%-4.0%) for patients with gastrointestinal, gynecologic, and prostate cancer, respectively. On multivariable analysis, being treated with IMRT (hazard ratio, 0.85; 95% CI, 0.73-0.99) or brachytherapy therapy alone (hazard ratio, 0.43; 95% CI, 0.34-0.54) was associated with a reduced hazard for pelvic fractures compared with 3D conformal radiation therapy in female patients. In contrast, there was no association with RT modality and the hazard for nonpelvic fractures among females. There was no significant association between pelvic fractures and IMRT or brachytherapy for male patients. White race, advanced age, and higher comorbidity were associated with an increased hazard for pelvic fracture. CONCLUSIONS: IMRT and brachytherapy were associated with a reduced risk of pelvic fractures in older women undergoing RT for pelvic malignancies. Pelvic insufficiency fracture risk should be considered when treating with pelvic RT.
PURPOSE: Older patients undergoing radiation therapy (RT) for pelvic malignancies are at increased risk for pelvic fracture, which is associated with significant morbidity and mortality. RT techniques such as brachytherapy or intensity modulated RT (IMRT) allow for more conformal dose distributions, but it is not known whether the risk for pelvic fracture varies by RT modality. METHODS AND MATERIALS: This observational cohort study involved 28,354 patients ≥65 years old, treated with RT for pelvic malignancies. We evaluated the relative risk of pelvic fracture by type of RT when accounting for baseline factors. To test for nonspecific effects, we also evaluated risk of nonpelvic fractures in the same population. RESULTS: The 5-year incidence of pelvic fractures was 12.7% (95% confidence interval [CI], 11.6%-13.8%), 11.8% (10.8%-12.8%), and 3.7% (3.4%-4.0%) for patients with gastrointestinal, gynecologic, and prostate cancer, respectively. On multivariable analysis, being treated with IMRT (hazard ratio, 0.85; 95% CI, 0.73-0.99) or brachytherapy therapy alone (hazard ratio, 0.43; 95% CI, 0.34-0.54) was associated with a reduced hazard for pelvic fractures compared with 3D conformal radiation therapy in female patients. In contrast, there was no association with RT modality and the hazard for nonpelvic fractures among females. There was no significant association between pelvic fractures and IMRT or brachytherapy for male patients. White race, advanced age, and higher comorbidity were associated with an increased hazard for pelvic fracture. CONCLUSIONS: IMRT and brachytherapy were associated with a reduced risk of pelvic fractures in older women undergoing RT for pelvic malignancies. Pelvic insufficiency fracture risk should be considered when treating with pelvic RT.
Authors: Nils H Nicolay; Eva Sommer; Ramon Lopez; Ute Wirkner; Thuy Trinh; Sonevisay Sisombath; Jürgen Debus; Anthony D Ho; Rainer Saffrich; Peter E Huber Journal: Int J Radiat Oncol Biol Phys Date: 2013-10-23 Impact factor: 7.038
Authors: Yevgeniya Jane Mikhailovna Ioffe; Travis J Hillen; Gongfu Zhou; Julie K Schwarz; L Stewart Massad; Matthew A Powell; Andrea R Hagemann; David G Mutch; Premal H Thaker Journal: Int J Gynecol Cancer Date: 2014-05 Impact factor: 3.437
Authors: Jennifer L Kelsey; Mila M Prill; Theresa H M Keegan; Charles P Quesenberry; Steven Sidney Journal: Am J Epidemiol Date: 2005-10-12 Impact factor: 4.897
Authors: Colleen A F Lawton; Jeff Michalski; Issam El-Naqa; Mark K Buyyounouski; W Robert Lee; Cynthia Menard; Elizabeth O'Meara; Seth A Rosenthal; Mark Ritter; Michael Seider Journal: Int J Radiat Oncol Biol Phys Date: 2008-10-22 Impact factor: 7.038
Authors: Casey W Williamson; Igor Sirák; Ronghui Xu; Lorraine Portelance; Lichun Wei; Rafal Tarnawski; Umesh Mahantshetty; Elena S Heide; Catheryn M Yashar; Michael T McHale; Walter Bosch; Jessica Lowenstein; Cheryl C Saenz; Steve Plaxe; Ramez Eskander; John Einck; Arno J Mundt; Jyoti Mayadev; Loren K Mell Journal: Int J Radiat Oncol Biol Phys Date: 2021-08-20 Impact factor: 7.038
Authors: Mehdi Boudissa; Geoffrey Porcheron; Daniel Wagner; Frank Traub; George Farah; Pol Maria Rommens Journal: Arch Orthop Trauma Surg Date: 2022-02-02 Impact factor: 3.067
Authors: Loren K Mell; Ronghui Xu; Catheryn M Yashar; Michael T McHale; John P Einck; Jyoti Mayadev; Euyhyun Lee; Pratibha Binder; Dominique Rash; Ramez Eskander; Elena S Heide; Steven C Plaxe; Arno J Mundt; Cheryl C Saenz Journal: Int J Radiat Oncol Biol Phys Date: 2020-04-22 Impact factor: 8.013